Cytospire Therapeutics is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Cytospire Therapeutics is a startup based in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Cytospire Therapeutics is a UK-based biotech company developing differentiated multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s own immune system. The company focuses on pan-gamma delta T cell engagers to overcome the limitations of conventional CD3 T cell engagers, particularly in solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.